🔎 Trials Near Me

홈 › 방광암 › 워싱턴

워싱턴의 방광암 임상 시험

방광암 관련 연구 25개가 워싱턴 내 여러 지역에서 참여자를 모집하고 있습니다.

워싱턴의 도시

공식 연구 텍스트(영어)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Valley Medical Center, Renton
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT03866382

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

  • Fred Hutchinson Cancer Center, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • University of Washington Medical Center - Montlake, Seattle
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07061964

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

  • University of Washington - Fred Hutchinson Cancer Center ( Site 0100), Seattle
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06833073

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  • Eye Associates Northwest - Edmonds Clinic, Edmonds
  • Eye Associates Northwest - Kirkland Clinic, Kirkland
  • Eye Associates Northwest - Ballard Clinic and Surgery Center, Seattle
  • 외 6개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • Swedish Cancer Institute, Seattle
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07277413

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

  • Fred Hutchinson Cancer Research Center ( Site 0787), Seattle
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07419295

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

  • University of Washington Fred Hutchinson Cancer Center, Seattle
피험자 모집 중1/2상
18세 ~ 99세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06814496

Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07667335

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06040762

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

  • Spokane Urology, Spokane
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06567743

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Providence Regional Cancer System-Aberdeen, Aberdeen
  • PeaceHealth Saint Joseph Medical Center, Bellingham
  • Providence Regional Cancer System-Centralia, Centralia
  • 외 19개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Madigan Army Medical Center, Tacoma
피험자 모집 중건강한 지원자 환영
45세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06995898

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT07579195

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • Spokane Urology, Spokane
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05951179

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 남성 · 2026. 8. 6. 업데이트됨 · NCT01050504

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT07225127

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  • Local Institution - 0200, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center - Montlake, Seattle
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • University of Washington School of Medicine, Seattle
피험자 모집 중2상
8세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT05503797

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  • Harborview Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center, Seattle
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT04879329

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

  • Research Site, Seattle
  • Research Site, Tacoma
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT07720284

Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT07302230

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Northwest Medical Specialities. PLLC, Bonney Lake
  • Swedish Cancer Institute - Edmonds Campus, Edmonds
  • Swedish Cancer Institute Edmonds Campus, Edmonds
  • 외 9개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT04389632

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • Fred Hutchinson Cancer Center, Seattle
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT06778863

Blue Light Cystoscopy With Cysview® Registry

  • University of Washington Medicine, Seattle
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2025. 12. 18. 업데이트됨 · NCT02660645

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Seattle
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.